ProCE Banner Activity

New Options in High-Risk Early Breast Cancer

Slideset

Download these slides from a live webinar on updates with oral targeted therapy for the treatment of high-risk early breast cancer.

Released: November 27, 2023

Share

Faculty

Kevin Kalinsky

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

Supported by educational grants from Merck Sharp & Dohme, LLC and AstraZeneca.

AstraZeneca

Merck Sharp & Dohme, LLC